Natalie T. Mills, MBBS, PhD, is affiliated with the Discipline of Psychiatry at Adelaide Medical School, University of Adelaide, Australia. Her publications focus on major depressive disorder, specifically investigating cognitive function and psychosocial dysfunction in affected patients. Her research includes clinical trials examining the effects of celecoxib combined with vortioxetine and the assessment of cognitive deficits using the THINC-Integrated Tool. Mills has frequently collaborated with Bernhard T. Baune, Célia Fourrier, Emma Sampson, Hikaru Hori, and Christa Hohoff.
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
